AKT1体细胞突变可能增加脑膜瘤患者术前癫痫发作风险
该单中心回顾性研究对1995至2018年间接受原发性脑膜瘤切除术的146例颅脑脑膜瘤患者进行肿瘤靶向测序,分析驱动突变与围手术期癫痫的关系。多变量分析显示AKT1突变和高血清肌酐与术前癫痫发作风险升高相关,手术年龄增大和低术前血清碳酸氢盐与术前癫痫风险降低相关;术前癫痫史与术后癫痫风险升高相关,而脑膜瘤切除术与术后癫痫风险降低相关。
要点
- AKT1突变和高血清肌酐与原发性脑膜瘤患者术前癫痫发作风险升高相关。
- 手术年龄增大和低术前血清碳酸氢盐与术前癫痫发作风险降低相关。
- 术前癫痫史与术后癫痫风险升高相关,脑膜瘤切除术与术后癫痫风险降低相关。
核心结论
- AKT1突变、高血清肌酐和手术年龄较小可能是原发性脑膜瘤患者术前癫痫发作的预测因素。
- 术前癫痫史预示术后癫痫风险升高,脑膜瘤切除术对术后癫痫发生具有保护作用。
- 这些分析可能通过帮助识别可能从早期术前抗癫痫药物使用中获益的患者来改善治疗模式。
研究设计与样本
- 单中心回顾性临床与基因组综述,纳入1995年至2018年间接受原发性脑膜瘤手术切除的患者。
- 肿瘤样本来自机构组织库,采用下一代靶向测序。
- 196例测序患者中146例为原发性颅脑脑膜瘤。
主要发现
- 146例原发性颅脑脑膜瘤患者中,36例(24.7%)发生术前癫痫,35例(24.0%)发生术后癫痫。
- 多变量分析显示AKT1突变和高血清肌酐与术前癫痫发作风险升高相关。
- 手术年龄增大和低术前血清碳酸氢盐与术前癫痫发作风险降低相关。
- 术前癫痫史与术后癫痫风险升高显著相关,脑膜瘤切除术与术后癫痫风险降低相关。
关键数值与推荐
- AKT1突变和高血清肌酐与术前癫痫发作风险升高相关。
- 手术年龄增大和低术前血清碳酸氢盐与术前癫痫发作风险降低相关。
- 术前癫痫史与术后癫痫风险升高显著相关。
- 脑膜瘤切除术与术后癫痫风险降低相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Seizure is an observed symptom for patients with newly diagnosed meningiomas. Recent progress has been made in the genomic characterization of meningiomas. However, it is currently unknown whether driver mutations associated with meningioma development also portend increased risk of perioperative seizure. We conducted a single center retrospective clinical and genomic review of patients who underwent primary meningioma resection to understand which mutations were associated with increased risk of perioperative seizure. METHODS: Tumor samples and clinical data were collected from an institutional tissue bank of patients who had a surgical resection of a primary meningioma between 1995 and 2018. Tumor samples were sequenced using next-generation targeted sequencing. Univariable models were used to select for relevant mutations for inclusion in the multivariate analysis. Multivariable models were built using selected variables and known clinical and demographic correlates of seizures. RESULTS: Of 196 sequenced patients in the cohort, 146 patients had primary cranial meningiomas. 36 patients (24.7%) experienced preoperative seizures, and 35 patients (24.0%) experienced postoperative seizures. With multivariable analysis, AKT1 mutation and high serum creatinine were associated with increased odds of preoperative seizures. Increased age at surgery and low preoperative serum bicarbonate were associated with decreased odds of preoperative seizure. Prior preoperative seizure was significantly associated with increased risk of developing postoperative seizure, and meningioma resection surgery was associated with decreased odds of developing postoperative seizure. CONCLUSION: Our study suggests that AKT1 mutation, high serum creatinine, and decreased age at surgery may be predictors of preoperative seizures in primary meningioma patients. In addition, prior preoperative seizures portended increased risk of postoperative seizure in this patient cohort and meningioma resection surgery was protective against the development of postoperative seizure. These analyses may improve treatment paradigms by helping to identify the patients who may benefit from earlier preoperative antiseizure medication usage.
引用
- Dedhia M, Devarajan A, Rao A, et al. Somatic AKT1 Mutations May Confer Increased Risk of Preoperative Seizures in Meningiomas. Neurosurgery. 2025. PMID: 40214250. doi:10.1227/neu.0000000000003445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。